C. Frank Bennett, EVP, Chief Scientific Officer at IONIS PHARMACEUTICALS INC (IONS), sold 20,536 shares at $83.58 ($1.7M) on 2026-07-07, disclosed to the SEC on 2026-07-09.
Scheduled sale ($1.7M) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.58 | 5,536 | $463K | 26.5% |
| 2 | $85.46 | 15,000 | $1.3M | 73.5% |
| Total | $84.95 avg | 20,536 | $1.7M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $976K | — | Filing → |
| IONS | SELL | 2026-01-20 | $675K | — | Filing → |
| IONS | SELL | 2025-09-09 | $358K | — | Filing → |